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Worldwide tobacco smoking kills nearly 6 million people each year, including more than 
600,000 non-smokers who die from smoke exposure. Tobacco smoke is a toxic and carcinogenic 
mixture of more than 5,000 chemicals. Environmental Tobacco Smoke (ETS), or secondhand 
smoke, is the combination of side stream smoke, the smoke given off by a burning tobacco product 
and mainstream smoke, the smoke exhaled by smokers. Exposure to Environmental Tobacco Smoke 
is detrimental to health which may pose a health risks to nonsmokers. Epidemiological data suggest 
that exposure to ETS may increase the risk of developing lung cancer, stroke, heart disease, 
cardiovascular disease, intrauterine growth retardaion, predisposition to chronic lung disease, 
sudden infant death syndrome and is a risk factor for childhood asthma. The human populations 
most at risk from ETS exposure appear to be neonates, young children, and possibly the fetus while 
in uterus. The effects of ETS on human health are well-known, passive smoking is harmful to those 
who breathe the toxins and it is a serious problem for public health. Therefore, the decrease in 
smoking prevalence could provide substantial health gains in humans. This article reviews 
information on environmental tobacco smoke (ETS) particles that are of potential interest to 
scientists and professionals involved in exposure or risk assessment, epidemiology, or tobacco 
policy and to compile effective ways of reducing exposure in order to contribute to the wellbeing of 
human. 
© 2016 International Formulae Group. All rights reserved. 




Tobacco  smoke  is  a  complex,  
dynamic  and  reactive  mixture  containing  
an  estimated  5,000 chemicals (Talhout et al., 
2011; Nikolić et al., 2012).  This toxic and 
carcinogenic mixture is probably the most 
significant source of toxic chemical exposure 
and chemically mediated disease in humans. 





In the recent years, the exposure to ETS has 
been an important public health hazard. 
Several  reports  have  also  emphasized  that  
exposure  to ETS can  cause  lung cancer in 
people who have never smoked (Pandey and 
Kim, 2010). It is a major risk factor for 
respiratory disease in children and the most 
important source of ETS exposure is within 
the home (Horak et al., 2007).  
ETS composed of side stream smoke 
(SS), the smoke emitted from the smoldering 
tobacco between puffs, and mainstream 
smoke (MS), the smoke from the smoker 
(Jenkins et al., 2000; WHO, 2000). The side 
stream smoke is shown to contain about the 
same hazardous substances as mainstream 
smoke. Quantitatively, however, side stream 
smoke contains much more of the different 
chemical constituents, varying from double to 
the hundred folded amounts for the different 
chemical constituents. This is due to the lower 
burning temperature between the “puffs”. 
More than 75% of the nicotine emitted from a 
cigarette is emitted into the air as side stream 
smoke (Pandey and Kim, 2010). 
Worldwide, tobacco smoking kills 
nearly 6 million people each year, including 
more than 600,000 non-smokers who die from 
smoke exposure. The World Health 
Organization estimates that approximately 
half of the children in the world are exposed 
to ETS mostly in their homes (Tsai et al., 
2010) and by 2030 tobacco will kill more than 
8 million people worldwide each year 
(Talhout et al., 2011; Giraldi et al., 2013). For 
instance, in Taiwan, school children are not 
typically exposed in public due to the 
legislative ban on public smoking and regular 
health promotion campaigns; home exposure 
is likely the dominant source of ETS. It was 
reported that approximately 60% Taiwanese 
children under the age of 17 were exposed to 
household ETS, and therefore an estimated 
3.3 million children were at risk for adverse 
health effects from this exposure (Tsai et al., 
2010).  
ETS exposure during pregnancy and 
the first years of life has been consistently 
found to have an impact on the respiratory 
system including symptoms such as wheezing, 
cough, bronchitis, otitis media and asthma, but 
also on intrauterine growth, sudden infant 
death, behavior and cognitive functioning 
(Horak et al., 2007). Exposure to the mother’s 
active smoking or maternal smoking affects 
the lungs of the fetus as it develops in uterus. 
Another explanation is that mothers are 
physically closer to their children while 
providing for their care during postnatal, thus 
exposing the children to a larger dose of ETS 
(Witschi et al., 1997). Prenatal and postnatal 
ETS exposure constitutes a determinant factor 
in respiratory morbidity in children and early 
lung function reduction. Various studies have 
demonstrated that ETS exposure adversely 
affects children’s respiratory health by 
diminishing lung growth and increasing the 
risk of infections and respiratory symptoms, 
including wheezing and asthma exacerbation. 
Children are exposed to tobacco smoke not 
only in their homes, but also in schools, 
restaurants, child care settings, cars, buses and 
other public places. In Ethiopia, parental 
smoking at home is likely the commonest 
source of children’s exposure to ETS (Horak 
et al., 2007).  
In 2004, an estimated 600,000 
individuals died of exposure to secondhand 
smoke, of which 53,000 were in Africa. These 
deaths were mostly caused by ischemic heart 
disease for adults and lower respiratory 
infections for children (WHO, 2011).  
National smoking prevalence among 
men in sub-Sahara Africa varies from 20% to 
60% and the annual cigarette consumption 
rates are on the rise for both men and women. 
Among sub-Saharan African youth, rates of 
smoking range from 1.4% in Zimbabwe and 
1.5% in Nigeria to 34.4% in Cape Town, 
South Africa, which is a cause for concern. In 
Kenya, 7.2% of school-going adolescents 
smoke cigarettes while 8.5% use other forms 
of tobacco products. In Ethiopia, in 1983 life 
time prevalence rate of cigarette smoking 
among college students was reported to be 
31.9% (Ahmed et al., 1984) and the 
prevalence of smoking among young 
Ethiopian (15–25 years of age) living in 
Addis-Ababa was 11.8% for males and 1.1% 
for females in 1995 (Rudatsikira et al., 2007).  





The most common tobacco smoke 
related causes of death, are cardiovascular 
disease, chronic obstructive pulmonary 
disease, and various types of cancer, in 
particular lung cancer. In addition, smoking 
tobacco is a major cause of illness and 
premature death (Pandey and Kim, 2010). 
Chronic obstructive pulmonary disease 
(COPD) is a leading cause of chronic 
morbidity and mortality. According to the 
Global Burden of Disease Study (Yildiz  et 
al., 2010), COPD was the 6th leading cause of 
death worldwide in 1990, and it is predicted to 
become the 3rd most common cause of death 
and the 4th most important disability-
producing illness by 2020 (Yildiz et al., 
2010). 
According to WHO,  more than 30% 
of world’s adult population is becoming 
consumers of tobacco and therefore it warns 
that a billion people will die of adverse health 
effects of tobacco epidemic within the 21st 
century unless effective measures are 
undertaken. The public health challenge of 
tobacco is unique in that tobacco producers 
undermine public health efforts because they 
gain unbelievably huge wealth, and power 
which enables them to endure all sorts of anti-
tobacco policies, and campaigns (Gedefaw et 
al., 3013). Therefore, obviously, there is a 
need for regulation of this addictive and 
harmful product as the most other addictive 
and/or hazardous products to which the 
population is exposed. So, it is important to 
understand the mechanisms through which 
ETS influences respiratory diseases in 
childhood to more effectively evaluate and 
implement interventions to reduce this burden. 
This review will focus primarily on impact of 
ETS on human health.  
 
TOBACCO SMOKE 
Tobacco smoke contains thousands of 
chemicals, many of which are poisonous. The 
following components of tobacco smoke 
contribute to disease: 
 Nicotine: an addictive drug found in 
tobacco smoke which causes blood vessels to 
contract and hence reducing blood flow. 
Therefore, nicotine increases blood pressure, 
which makes the heart work harder and also 
affects brain and muscle activity. 
 Carbon monoxide: decreases 
oxygen intake which in turn reduces the 
amount of oxygen delivered to the heart by 
taking the place of oxygen in the blood and 
thereby makes the heart beat faster 
(Stefanadis, 2008).  
 Tar : coats the lungs like soot in a 
chimney making it harder to breath. Tar in 
tobacco contains dozens of chemicals that 
cause cancer. Of the 4,000 chemicals in 
tobacco smoke, 50 are associated with causing 
cancer and promoting tumor growth. 
 
COMPONENTS OF ETS  
Humans may be exposed to a variety 
of chemical hazards. Tobacco smoking 
constitutes a significant source of indoor air 
pollution. Carbonyl compounds, including 
formaldehyde, have been shown to be major 
air pollutants. A large number of chemical 
compounds present in the mainstream and 
side stream smokes are carcinogenic and also 
cause long-term toxic effects. Its composition 
depends on the content of compounds present 
in the tobacco plant and the various 
ingredients added to tobacco during the 
manufacturing process (Demkowska et al. 
2010).  
Emissions contain both particulate 
and vapour contaminants. When a cigarette is 
smoked, roughly half of the smoke generated 
is SS and the other half MS. Side stream 
smoke and mainstream smoke are complex 
mixtures of over 4000 compounds (Table 1) 
(Matt et al., 2004). These include more than 
40 known or suspected human carcinogens 
and a number of irritants, such as ammonia, 
nitrogen oxides, etc. are found in tobacco 
which are shown in Table 2 (WHO, 2000). 
 
ENVIRONMENTAL TOBACCO SMOKE 
EXPOSURE AND ITS HEALTH 
EFFECTS   
Exposure is defined as the contact of 
pollutant with a susceptible surface of the 
human body. For environmental tobacco 
smoke, this means contact with the eyes, the 
epithelium of the nose, mouth and throat, and 





the lining of the airways and alveoli (Jaakkola 
and Jaakkola, 1997). The smoke accumulates 
in enclosed spaces and the concentration 
varies with the number of smokers, with the 
type of smoking, and with the characteristics 
of the room, especially the ventilation 
(Trédaniel et al., 1994). ETS involves inhaling 
carcinogens and other toxic components, and 
scientific evidence has  unequivocally  
established  that  exposure  to  ETS causes  
death,  disease,  and  disability  in  children  
and adults who do not smoke (Phillips et al., 
1994). People may be exposed to 
environmental tobacco smoke in homes, cars, 
workplaces (Phillips et al., 1994), and public 
places, such as bars, restaurants, and 
recreational settings. In addition, there is 
another type of smoke which until now has 
not been considered: the so-called third hand 
smoke (Figure 1), that comes from the rests of 
active smoking nicotine (mainstream smoke) 
that is laid down on the surfaces of indoor 
environments (cars, clothes, curtains, 
wallpaper, etc.) and reacts with environmental 
nitrous acid (HNO2) making carcinogenic 
tobacco-specific nitrosamines (TSNAs). One 
of the most alarming characteristics of TSNAs 
is their longevity: they are among the most 
broadly acting and potent carcinogens present 
in burned tobacco and tobacco smoke. 
According to the Environment 
Protection Agency, tobacco smoke is 
classified as group A carcinogen since it has 
been proved that about 60 components of 
tobacco smoke have carcinogenic 
characteristics. Cigarette smoke irritates 
especially the mucous membranes of the eye, 
nose, and upper respiratory organs causing 
inflammation of the sinuses, throat, vocal 
cords, bronchi, and contributes to the 
development of emphysema and lung cancer 
(Jaakkola and Jaakkola, 2002; Goniewicz et 
al., 2009). Because of the long-term swelling 
and changes in the mucosa of the nose, the 
sense of smell can gradually weaken due to 
the damage of the olfactory nerve. Harmful 
ingredients of tobacco smoke disrupt the 
normal function of bronchial epithelium and 
stimulate the secretion of bronchial mucus 
(Houtmeyers et al., 1999). 
Exposure  to  tobacco  smoke  leads  
to  more  frequent  use  of health care, absence 
from work, and in most cases hospitalization 
for respiratory diseases. The female 
population is a special category that needs 
attention because exposure to tobacco smoke 
can also seriously affect fertility and may lead 
to complications in pregnancy and childbirth. 
Furthermore, prenatal exposure to cigarette 
smoke affects health of the newborn infant 
and his/her subsequent school performance. 
Some studies demonstrated that women 
married to smokers are at higher risk of lung 
cancer, ovarian, and endometrial cancer 
(Badran et al., 2009). Figure 2 shows all of the 
systems in the body that tobacco smoke 
affects, both to the smoker and to someone 
who ingests secondhand smoke. 
 
SERIOUS DISEASES CAUSED BY 
PASSIVE SMOKING 
ETS exposure during pregnancy and 
the first years of life has been consistently 
found to have an impact on the respiratory 
system including symptoms such as wheezing, 
cough, bronchitis, RSV bronchiolitis, otitis 
media and asthma, but also on intrauterine 
growth, sudden infant death, behavior and 
cognitive functioning (Horak, 2007). People 
who regularly spend time in rooms where 
others smoke are at increased risk for many 
diseases and disorders. These also include 
serious diseases such as cancers, 
cardiovascular and respiratory diseases which 
require a lot of treatment and can permanently 
affect a person‘s quality of life; they can 
sometimes be fatal (GBE Kompakt, 2010).  
 
Lung cancer 
Environmental tobacco smoke is a 
major risk factor for respiratory disease. More 
than 69 of the 4800 chemical compounds in 
tobacco smoke cause cancer in animals, 
including humans. These carcinogenic 
substances irritate the cells lining the 
respiratory passages and alter their metabolic 
balance. Normal cells are transformed into 
cancer cells, which may multiply rapidly and 
invade surrounding tissues (Solomon et al., 
2011). The evidence on ETS and lung cancer 





has been assessed by many health 
organizations, all of which concluded that 
exposure to ETS increases the risk of lung 
cancer (Environmental Tobacco Smoke, 
2000). According to Postlethwait and Hopson 
(2006) tobacco smoke has been found to be 
the cause of more than 85 percent of all lung 
cancers. Thousands of non-smokers die of 
lung cancer each year as a result of breathing 
secondhand tobacco smoke. There is no safe 
level of tobacco smoke. Well-known 
carcinogens include the chemicals in tobacco 
smoke, asbestos, and ionizing radiation, such 
as X rays or Ultraviolet light from the sun. 
Evidence also shows that the risk of 
developing lung cancer is increased by up to 
30 percent in nonsmokers who live with an 
individual who smokes in the house, as 
compared to non-smokers who are not 
regularly exposed to secondhand smoke. 
According to the Centers for Disease Control, 
in the United States of America, the single 
most preventable cause of disease, disability, 
and death is tobacco use. Cigarette smoking 
kills more people than alcohol, car accidents, 
suicide, AIDS, homicide, and illegal drugs 
combined. More than 443,000 people die 
prematurely each year from smoking or 
exposure to second-hand smoke. Tobacco 
smoke is by far the most important risk factor 
for lung cancer, the most common lethal 
cancer worldwide (Solomon et al., 2011). 
 
Developmental and pregnancy problems 
A woman who actively smokes 
during pregnancy substantially increases her 
risk of delivering a low birth-weight infant. 
Women who do not smoke during pregnancy 
may still be exposed to environmental tobacco 
smoke (ETS) (De Lorenze et al., 2002). 
Maternal cigarette smoking during 
pregnancy is associated with increased risk of 
miscarriage, intrauterine growth retardation, 
preterm delivery, reduced infant weight, and 
higher infant mortality. Many studies have 
also suggested that the pregnant woman’s 
exposure to her partner’s smoking may 
contribute to reduced birth weight (Windham, 
1999); paternal smoking also increases the 
risk of infant respiratory infections and 
sudden infant death syndrome, irrespective of 
the maternal smoking status (Wright et al., 
1998; Cook and Strachan, 1999; Goel et al., 
2004). 
Fetuses, neonates, and  young  
children are most at risk from ETS exposure. 
ETS exposure may not only harm the 
respiratory system, but also cause adverse 
reproductive and prenatal outcomes including 
spontaneous abortion, decreased birth weight, 
preterm delivery, intrauterine growth 
retardation and sudden infant death syndrome 
(Su et al., 2007). 
 
Asthma 
Asthma is a common respiratory 
disease resulting from an interaction between 
genetic susceptibility for this disease and 
exposure to various environmental factors. It 
is a chronic lung disease that inflames and 
narrows airways and causes symptoms such as 
wheezing, chest tightness, shortness of breath, 
and coughing. Tobacco smoking and exposure 
to ETS are some of the several important 
variables which are likely to affect the 
incidence, recognition and clinical 
presentation of asthma. Environmental 
tobacco smoke exposure as a risk factor for 
asthma and respiratory symptoms is now well 
accepted in children. There are several studies 
on the effects of parental smoking on 
childhood asthma (Gupta et al., 2006; Rushton 
et al., 2003). Adults with asthma can 
experience a significant decline in lung 
function when exposed, while new cases of 
asthma may be induced in children whose 
parents smoke. Immediate effects of exposure 
to second hand smoke include eye irritation, 
headache, cough, sore throat, dizziness and 
nausea. Short term exposure to tobacco smoke 
also has a measurable effect on the heart in 
nonsmokers (Otsuka, 2001). 
As study conducted by Quinto et al.
(2013), in girls with asthma, 57.6% 
experienced ETS exposure, while 43.6% of 
girls without asthma had ETS exposure. No 
difference was seen in the percentage exposed 
to ETS between boys with asthma (50.8%) 
and without asthma (44.7%) (Figure 3). 
 





MINIMIZING EXPOSURE TO ETS 
Although community efforts to 
increase cessation and reduce initiation of 
tobacco use will also eventually reduce ETS 
exposures, additional interventions are 
necessary to provide immediate protection for 
non-smokers in workplaces, public areas, and 
home environments. Here are some ways to 
minimize your exposure as well as your risk 
of disease:  
 Adopt a non-smoking policy in your 
home. Try to quit or cut back on smoking to 
improve your health and your children 
 Avoid smoking around other people 
to reduce their exposure to second-hand 
smoke. 
 Avoid smoking indoors, especially in 
areas that are not well ventilated, to reduce 
second-hand and third hand smoke. 
 Avoid areas where you know there is 
a chance for smoke to irritate your allergies or 
sensitivities. 
 Help children avoid second-hand 
smoke of smokers who use tobacco around 
them. Have them leave the room or play 
outside while an adult is smoking. Air rooms 
out after smoking occurs. Keep smokers away 
from children’s sleeping areas. 
 Non-smokers can reduce their 
exposure to second-hand smoke by avoiding 
indoor areas where people smoke or by 
establishing a smoking ban in their homes or 
workplaces. 
 Parents who smoke should cover 
their clothes with a clean jacket or smock 
before picking up or holding a baby. 
 
Conclusion 
Environmental tobacco smoke is the 
combination of two forms of smoke from 
burning tobacco products: Side stream smoke 
(SS)—smoke emitted between the puffs of a 
burning cigarette, pipe, or cigar and 
Mainstream smoke (MS)—the smoke exhaled 
by the smoker. Exposure to environmental 
tobacco smoke (ETS) is widespread in the 
world, the most serious exposures occurring at 
homes, cars, and public places, such as bars, 
restaurants, and recreational settings and in 
the workplace. It is known to be a human 
carcinogen based on sufficient evidence of 
carcinogenicity from studies in humans. For 
instance, exposure to environmental tobacco 
smoke leads to very serious health effects, 
especially on the respiratory system. The 
effects of ETS on human health are well-
known, passive smoking is harmful to those 
who breathe the toxins and it is a serious 
problem for public health. Therefore, the 
decrease in smoking prevalence could provide 
substantial health gains in humans. 
 
 
Table 1: Examples of Toxic Constituents in Tobacco Smoke (from over 4,000 identified chemicals) 







Gaseous substances Nitrosamines Metals 
1,3-butadiene Benzo(a)pyrene Ammonia NNN Lead 
Benzene  Pyrene Hydrogen cyanide NAB Cadmium 

















Table 2: Emissions of selected tobacco smoke constituents in fresh, undiluted mainstream smoke 
(MS) and diluted side stream smoke (SS) from unfiltered cigarettes. 
 
Constituent Emissions in MS SS/MS ratio 
Known Human Carcinogens   
• Benzene 12-48 µg 5-10 
• 2-Naphthylamine 1.7 ng 30 
• 4-Aminobiphenyl 4.6 ng 31 
• Nickel 20-80 ng 13-30 
• Polonium-210 0.04-0.1 pCi 1-4 
Probable Human Carcinogens   
• Formaldehyde 70-100 µg 0.1-50 
• Hydrazine 32 ng 3 
• N-Nitrosodimethylamine 10-40 ng 20-100 
• N-Nitrosodiethylamine ND-25 ng <40 
• N-Nitrosopyrrolidine 6-30 ng 6-30 
• 1,3-Butadiene 69.2 µg 3-6 
• Aniline 360 ng 30 
• Benzo[a]pyrene 20-40 ng 2.5-3.5 
• N-Nitrosodiethanolamine 20-70 1.2 
• Cadmium 110 ng 7.2 
Toxic Substances   
• Carbon Monoxide 10-23 mg 2.5-4.7 
• Acrolein 60-100 µg 8-15 
• Ammonia 50-130 µg 3.7-5.1 
• Nitrogen Oxides 100-600 µg 4-10 





Table 3: Variety of illnesses in both adults and children due to ETS. 
 
Adults  Children  
Lung cancer  Asthma  
Heart disease  Bronchitis  
Increased stroke risk  Cot death 
Nasal cancer Low birth weight 
 Middle ear infection  
 Pneumonia  
Smoke lines (2000) an occasional information sheet for community opinion leaders. 
 
 






Figure 1: Mechanism of ETS formation. Side stream and mainstream smoke originate from 
cigarette; third hand smoke is the reaction of mainstream smoke and the environmental nitrous acid 





Figure 2: The health consequences causally linked to smoking and exposure to second-hand smoke. 
(Adapted from U.S. Department of Health and Human Services, 2010). 
 







Figure 3: Percentage of children aged 3-19 years exposed to ETS by asthma status and sex. 
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